# Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

> **NCT03676881** · — · UNKNOWN · sponsor: **Bruyère Health Research Institute.** · enrollment: 36 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia
- Neuropathology
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** Computerized cognitive battery: Cognigram (CG)
- **DEVICE:** The NeuroCatch™ Platform (NCP)

## Key facts

- **NCT ID:** NCT03676881
- **Lead sponsor:** Bruyère Health Research Institute.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-04
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03676881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03676881, "Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03676881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*